Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart disease and sleep apnea—and the U.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy drinking episodes in adults.

A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol and cocaine.

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol. A new study confirms there's likely something to the anecdotes, with a staggering 30 percent reduction in alcohol consumption per drinking day for those given the medication,

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.